Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABVX Abivax S.A.

Market Closed 08-28 16:00:00 EDT

113.35

-0.95

-0.83%

盘后113.35

+0.000.00%

18:44 EDT

High115.17	Low111.72	Vol926.19K
Open114.34	D1 Closing114.30	Amplitude3.02%
Mkt Cap9.87B	Tradable Cap8.67B	Total Shares87.05M
T/O104.73M	T/O Rate1.21%	Tradable Shares76.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":113.35,"timestamp":1787947200000,"preClose":114.3,"halted":0,"volume":926191,"hourTrading":{"tag":"盘后","latestPrice":113.35,"preClose":113.35,"latestTime":"18:44 EDT","volume":1904,"amount":215818.87,"timestamp":1787957092029,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008311461067366605,"floatShares":76455400,"shares":87054500,"eps":-5.216782,"marketStatus":"Market Closed","change":-0.95,"latestTime":"08-28 16:00:00 EDT","open":114.34,"high":115.17,"low":111.7229,"amount":104730862.65936,"amplitude":0.030158,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.216782,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":114.3,"preHourTrading":{"tag":"盘前","latestPrice":114.46,"preClose":114.3,"latestTime":"09:29 EDT","volume":3827,"amount":439583.03547,"timestamp":1787923768435,"change":0.16,"changeRate":0.0014,"amplitude":0.013386},"postHourTrading":{"tag":"盘后","latestPrice":113.35,"preClose":113.35,"latestTime":"18:44 EDT","volume":1904,"amount":215818.87,"timestamp":1787957092029,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9807408036874359,"impliedVol":0.6864,"impliedVolPercentile":0.1435},"requestUrl":"/m/hq/s/ABVX/tweets","defaultTab":"tweets","newsList":[{"id":"2655601383","title":"Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2655601383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655601383?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383141","title":"Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383141?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441907,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138028006","title":"Movement Alert｜Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180","url":"https://stock-news.laohu8.com/highlight/detail?id=1138028006","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138028006?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:01","pubTimestamp":1785423662,"startTime":"0","endTime":"0","summary":"On July 30, Abivax S.A. rose 5.18% in regular trading, trading at $124.4/share, with turnover of $55.49 million. The rally was driven by Morgan Stanley significantly raising its price target on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653822600","title":"Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2653822600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653822600?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:47","pubTimestamp":1784897275,"startTime":"0","endTime":"0","summary":"Abivax's  drug obefazimod for the potential treatment of ulcerative colitis patients has shown promising clinical results, with experts seeing the potential for \"broad uptake\" of the drug in the long term, Morgan Stanley said in a note to investors on Friday.Sentiment on lingering regulatory and labeling concerns has also improved as clinical data has come in, the note said.Experts and opinion leaders were \"unanimously positive\" on obefazimod's efficacy, suggesting \"broad opportunity\" for obefazimod, the note said.The drug's benefits outweigh potential risks of overly strict labeling or long-term adverse effects, the note said.\"Clear from our conversations is the near-unanimous support for obefazimod's efficacy profile, particularly on endoscopic measures,\" the note said.Morgan Stanley rated Abivax overweight and raised its price target to between $159 and $202, from the previous $97 to $157.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653083983","title":"Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2653083983","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653083983?lang=en_us&edition=fundamental","pubTime":"2026-07-24 17:47","pubTimestamp":1784886456,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) has an average rating of buy and mean price target of $162.06, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653773710","title":"Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2653773710","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653773710?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:13","pubTimestamp":1784837624,"startTime":"0","endTime":"0","summary":"Abivax names new global heads of marketing, sales and market access in commercial leadership shake-upAbivax expanded its commercial leadership team with four senior hires as it prepares a potential US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL4VGb0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652287827","title":"Abivax re-engages Centerview amid renewed takeover interest, La Lettre says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652287827","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652287827?lang=en_us&edition=fundamental","pubTime":"2026-07-18 02:10","pubTimestamp":1784311814,"startTime":"0","endTime":"0","summary":"Marc de Garidel’s company suspended takeover talks with pharma giants including AstraZeneca (AZN) and Eli Lilly (LLY) last month as it secured an E...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-re-engages-centerview-amid-renewed-takeover-interest-la-lettre-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-re-engages-centerview-amid-renewed-takeover-interest-la-lettre-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651644362","title":"Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2651644362","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651644362?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:08","pubTimestamp":1784196523,"startTime":"0","endTime":"0","summary":"Valerio Therapeutics said Thursday it has entered into a binding term sheet with Abivax  for an exclusive worldwide research and development collaboration to develop next-generation therapies for immune-mediated inflammatory diseases.Under the agreement, the company said it could receive up to 2.4 million euros  upfront, along with potential development and commercial milestone payments and royalties, subject to the execution of a definitive co-ownership and license agreement.The companies will collaborate on the discovery, manufacturing and preclinical evaluation of therapeutic candidates, with Abivax retaining the option to advance selected programs into further development.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650926264","title":"Abivax price target raised to $175 from $165 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2650926264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650926264?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:21","pubTimestamp":1783596090,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Abivax (ABVX) to $175 from $165 and keeps an Overweight rating on the shares. The firm is raising i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-175-from-165-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-175-from-165-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679769","title":"Abivax Closes $920 Million ADS Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679769","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679769?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:21","pubTimestamp":1783369279,"startTime":"0","endTime":"0","summary":"Abivax  said Monday it closed its previously announced public offering of 7.36 million American depositary shares, including the full exercise of the underwriters' option to purchase additional ADSs.The offering generated aggregate gross proceeds of approximately $920 million, with estimated net proceeds of approximately $874.1 million, according to a statement.Abivax said the net proceeds, together with its current cash and cash equivalents, will fund operations into Q4 of 2029.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649281620","title":"Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2649281620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649281620?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:12","pubTimestamp":1783350766,"startTime":"0","endTime":"0","summary":"Abivax  shares have rebounded to pre-Phase 3 maintenance data levels as investor concerns over malignancy rates eased, but obefazimod is unlikely to displace JAK inhibitors in inflammatory bowel disease, Wedbush said in a report Monday.The firm said \"malignancy rates\" associated with obefazimod's 50-milligram dose appear comparable with those seen with approved JAK inhibitors, including market leader AbbVie's  Rinvoq, suggesting the safety profile is unlikely to significantly limit commercial adoption, according to the report.However, the firm said that claims obefazimod is \"best in disease\" are not supported by the data, noting its \"induction\" efficacy in biologic-experienced patients lagged Rinvoq's, although maintenance results were broadly comparable. The analysts expect obefazimod to find a role in patients previously treated with JAK inhibitors rather than replace the class.The report also said the likelihood of a near-term acquisition has diminished, citing reduced interest from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649626839","title":"Abivax Sa : Wedbush Raises Target Price to $140 from $110","url":"https://stock-news.laohu8.com/highlight/detail?id=2649626839","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649626839?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:09","pubTimestamp":1783336167,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649162535","title":"Wedbush Raises Price Target on Abivax to $140 From $110, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2649162535","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649162535?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:52","pubTimestamp":1783335154,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) has an average rating of buy and mean price target of $156.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120085619","title":"Movement Alert｜Abivax S.A. Rises 6.46% in Pre-Market Trading, $920 Million ADS Offering Officially Closes Boosting Bullish Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1120085619","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120085619?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:07","pubTimestamp":1783325247,"startTime":"0","endTime":"0","summary":"On July 6, Abivax S.A. rose 6.46% in pre-market trading, trading at $152.5/share, with turnover of $580,000. The stock continues to trade well above the $125 offering price.On the news front, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182435348","title":"Movement Alert｜Abivax S.A. Rises 5.74% Overnight, $920 Million ADS Offering Officially Closes as Underwriters Fully Exercise Over-Allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1182435348","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182435348?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:02","pubTimestamp":1783321325,"startTime":"0","endTime":"0","summary":"On July 6, Abivax S.A. rose 5.74% overnight, trading at $155.04/share, with turnover of $1.27 million. The movement was driven by the formal closing of the company's expanded equity offering, which...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188703620","title":"Movement Alert｜Abivax S.A. Rises 5.39% in Regular Trading, Underwriters Fully Exercise Overallotment Option Lifting Total Proceeds to $920 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1188703620","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188703620?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:37","pubTimestamp":1782999445,"startTime":"0","endTime":"0","summary":"On July 2, Abivax S.A. rose 5.39% in regular trading, trading at approximately $140.64 per share, with turnover of $67.40 million.On the news front, the company announced that underwriters of its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648312502","title":"Abivax Sa : Truist Securities Raises Target Price to $155 from $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2648312502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648312502?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:41","pubTimestamp":1782992503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504690","title":"Abivax price target raised to $155 from $135 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504690?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:15","pubTimestamp":1782990943,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Abivax (ABVX) to $155 from $135 and keeps a Buy rating on the shares. ollowing maintenance Part 2 data, di...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-155-from-135-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-155-from-135-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648458508","title":"Abivax Says Underwriters Fully Exercise Option in ADS Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648458508","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648458508?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:43","pubTimestamp":1782981835,"startTime":"0","endTime":"0","summary":"Abivax  said Thursday the underwriters of its American depositary share offering exercised in full their option to purchase an additional 960,000 ADSs, increasing gross proceeds to about $920 million.The offering is expected to close Monday, subject to customary closing conditions.Net proceeds, about $874.1 million, will be used to support the potential US commercialization of obefazimod, clinical research on ulcerative colitis and Crohn's disease, and for general corporate purposes, the company said.Shares of Abivax were 5% higher in Thursday's premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508197","title":"Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508197","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648508197?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:30","pubTimestamp":1782981020,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX) w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-scynexis-scyx-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-scynexis-scyx-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","BK4007","LU0029874061.USD","XLV","HCSG","BK4137","AAVXF","LU0128526141.USD","BK4585","ABVX","LABU","SCYX","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.0139},{"period":"1month","weight":-0.0462},{"period":"3month","weight":-0.1454},{"period":"6month","weight":-0.0654},{"period":"1year","weight":0.3884},{"period":"ytd","weight":-0.1595}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}